Wave Life Sciences (WVE) Net Income Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.28% |
| Dec 31, 2025 | -13.03% |
| Sep 30, 2025 | -10.22% |
| Jun 30, 2025 | -4.48% |
| Mar 31, 2025 | 0.26% |
| Dec 31, 2024 | 20.26% |
| Sep 30, 2024 | -4.02% |
| Jun 30, 2024 | 4.73% |
| Mar 31, 2024 | 6.52% |
| Dec 31, 2023 | 15.54% |
| Sep 30, 2023 | 17.00% |
| Jun 30, 2023 | 10.08% |
| Mar 31, 2023 | 4.91% |
| Dec 31, 2022 | -7.90% |
| Sep 30, 2022 | -8.88% |
| Jun 30, 2022 | -10.92% |
| Mar 31, 2022 | -12.38% |
| Dec 31, 2021 | -13.20% |
| Sep 30, 2021 | 18.70% |
| Jun 30, 2021 | -27.37% |
| Mar 31, 2021 | -40.17% |
| Dec 31, 2020 | -32.35% |
| Sep 30, 2020 | -46.32% |
| Jun 30, 2020 | -61.40% |
| Mar 31, 2020 | -68.80% |
| Dec 31, 2019 | -100.57% |
| Sep 30, 2019 | -106.13% |